October 2024
The global vials used in compounding pharmacy market is surging, with an overall revenue growth expectation of hundreds of millions of dollars during the forecast period from 2024 to 2033. Projected revenue growth is set to skyrocket while the market held a notable share in 2023.
The vials used in compounding pharmacy market deals with the manufacturing and distribution of vials used in compounding pharmacy. The practice that uses tools to help compound prescription drugs into forms that are helpful is known as pharmaceutical compounding. Take note of the equipment, techniques, and diverse compounding settings that are employed for distinct drugs. Even in the narrow range of vials, there is a vast array of choices, ranging from traditional glass vials to cutting-edge smart vials. An exceedingly useful yet basic tool is the pharmaceutical vial. These little plastic or glass receptacles have distinctive features and are available in a variety of sizes and forms. Pharmacy staff may maintain patient safety and compliance by being aware of how each kind of vial functions. The changes in the vials used in compounding pharmacy market are happening quickly. Worldwide pharmacies depend on telepharmacy and other technology to provide prompt and effective patient care. Prescription packaging solutions, such as pharmacy vials, are also seeing advancements in technology.
| Company Name | Hikma Pharmaceuticals PLC |
| Headquarters | London, United Kingdom |
| Recent Launch | In December 2023, the USP formulations of phenylephrine HCl Injection, 500 mcg/5 mL and 1,000 mcg/10 mL, are now available from Hikma Pharmaceuticals PLC (Hikma), a global pharmaceutical firm. In the US, the medication was introduced in vials that were ready to use. When an adult is under anesthesia and has clinically significant hypotension, mainly from vasodilation, it is suggested to raise blood pressure. |
| Company Name | SGD Pharma |
| Headquarters | Telangana, India |
| Recent Launch | In October 2023, the Sterinity line of ready-to-use (RTU) Type I molded glass vials was expanded, according to SGD Pharma. Customers who will gain from greater flexibility as a result of the expanded range will profit from the introduction of two new sizes, 10H ml and 20H ml in trays. |
The vials used in compounding pharmacy market are growing due to the growing utilization of drugs due to the increasing number of patients. A unique kind of glass vial known as an ampoule can also be used to deliver a wide variety of medications, both liquid and solid. Ampoules are typically used to hold substances and medications that are sensitive to air or for which sterility and an inert container are essential. To improve the stability of the solid or liquid medication, ampoules can also be used to hold gases or to pressurize the ampoule with a specific gas. It is also possible to modify the ampoule's glass to block dangerous UV rays.
Contamination is one of the limitations of using ampules. The ampoule's contents could get contaminated by glass fragments that break or by metal flakes that are used to make the ampoule. When injected or inhaled, as is the case with anesthetics, these pollutants can manifest health risks. In addition, the substances utilized in the packaging of the ampoule can expose patients to the possibility of bacterial infections. Opening an ampoule could be hazardous for medical personnel because you have to break through the glass.
Corning, like a lot of other top producers of primary glass packaging, has modified its production processes to reduce emissions as the pharmaceutical business sets aggressive targets for material waste and carbon reduction. A cascade effect of lower energy used in raw material extraction, lower emissions during transportation, better utilization of secondary packaging materials, and lower energy consumption during conversion is produced when fewer glass materials are used per vial. The annual inflow of roughly 30,000 tons (>27 million kg) of glass into the trash stream might be prevented by a 20% reduction in glass material.
For instance,
North America dominated the vials used in compounding pharmacy market in 2023. The primary drivers propelling the market growth are the growing need for customized drugs, the incidence of chronic illnesses on the rise, the development of the healthcare infrastructure, and the growing awareness and desire for complementary therapies. Because it is more affordable to invest in cutting-edge medications that cater to specific medical demands, North America has been the driving force behind advancements in the healthcare sector.
Considering the region's enormous growth potential in all areas, growth is mostly attributable to favorable development conditions, such as the residential market's recovery and improved affordability, along with growing pharmacy penetration in North America throughout the projected period. The environment of retail pharmacies, which are defined as pharmacies that fill prescription drugs, has changed significantly during the last 20 years. The vials used in compounding pharmacy market growth have been positively impacted by the quick expansion and upgrades of existing pharmacies to increase market penetration.
Asia Pacific is expected to grow at the fastest rate during the forecast period. The nations of China, Japan, India, South Korea and the rest of Asia Pacific are included in the Asia Pacific region. The expansion of the market in the area is also fueled by the presence of several industry participants. The market for compounding pharmacies in the Asia Pacific area will also rise as a consequence of increased research and development efforts aimed at improving a number of healthcare outcomes and generating more exact and accurate results. Over the projection period, the market for vials used in compounding pharmacies will be driven by rising rates of chronic illnesses and an increase in the senior population, which will also put more strain on the healthcare system.
October 2024
October 2024
October 2024
October 2024
Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.